ING Groep NV Buys 295,785 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

ING Groep NV boosted its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 34.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,163,087 shares of the company's stock after buying an additional 295,785 shares during the period. ING Groep NV owned approximately 0.93% of Henry Schein worth $80,486,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in HSIC. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Henry Schein by 2.7% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,994 shares of the company's stock worth $947,000 after buying an additional 340 shares in the last quarter. Blue Trust Inc. raised its holdings in Henry Schein by 157.0% in the 3rd quarter. Blue Trust Inc. now owns 2,393 shares of the company's stock worth $174,000 after acquiring an additional 1,462 shares during the last quarter. Tempus Wealth Planning LLC lifted its position in Henry Schein by 16.1% in the 3rd quarter. Tempus Wealth Planning LLC now owns 5,348 shares of the company's stock valued at $390,000 after acquiring an additional 741 shares in the last quarter. Assenagon Asset Management S.A. boosted its stake in Henry Schein by 772.1% during the 3rd quarter. Assenagon Asset Management S.A. now owns 254,580 shares of the company's stock valued at $18,559,000 after purchasing an additional 225,388 shares during the last quarter. Finally, Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after purchasing an additional 170 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Henry Schein stock traded down $0.81 during trading on Friday, reaching $77.24. The company had a trading volume of 3,295,278 shares, compared to its average volume of 1,508,673. The firm has a market capitalization of $9.63 billion, a price-to-earnings ratio of 31.79, a price-to-earnings-growth ratio of 2.12 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm's 50-day simple moving average is $74.14 and its 200 day simple moving average is $72.21. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HSIC. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price on the stock. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Finally, Barrington Research raised their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an "outperform" rating in a report on Thursday, January 30th. Eight equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $80.09.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.